https://www.technologynetworks.com/cancer-research/news/melanoma-clinical-trial-reveals-success-of-drug-combination-368555
A combination of a common immunotherapy drug with all-trans retinoic acid, a chemotherapeutic, has shown promise in clinical trials.
Create an account or login to join the discussion